Astrana Health (NASDAQ:ASTH) Hits New 52-Week Low – Here’s Why

Shares of Astrana Health, Inc. (NASDAQ:ASTH) hit a new 52-week low during mid-day trading on Friday . The stock traded as low as $32.54 and last traded at $32.83, with a volume of 53825 shares trading hands. The stock had previously closed at $33.53.

Wall Street Analysts Forecast Growth

A number of analysts recently commented on ASTH shares. Macquarie upgraded shares of Astrana Health to a “hold” rating in a research report on Monday, December 16th. TD Cowen initiated coverage on Astrana Health in a research report on Monday, October 14th. They set a “buy” rating and a $66.00 price target on the stock. BTIG Research lifted their price objective on Astrana Health from $60.00 to $70.00 and gave the company a “buy” rating in a report on Thursday, October 3rd. KeyCorp assumed coverage on Astrana Health in a research note on Friday, October 11th. They set a “sector weight” rating for the company. Finally, Robert W. Baird lifted their price target on shares of Astrana Health from $67.00 to $86.00 and gave the company an “outperform” rating in a research note on Wednesday, November 13th. Two equities research analysts have rated the stock with a hold rating, six have assigned a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $65.17.

Astrana Health Trading Down 2.4 %

The business has a 50-day moving average of $44.45 and a 200-day moving average of $47.57. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91. The firm has a market cap of $1.84 billion, a price-to-earnings ratio of 25.17, a P/E/G ratio of 1.80 and a beta of 1.13.

Astrana Health (NASDAQ:ASTH) last released its earnings results on Thursday, November 7th. The company reported $0.33 earnings per share for the quarter, meeting the consensus estimate of $0.33. Astrana Health had a net margin of 3.63% and a return on equity of 9.37%. The business had revenue of $478.71 million during the quarter, compared to analysts’ expectations of $462.01 million. During the same period last year, the business earned $0.47 earnings per share. Research analysts anticipate that Astrana Health, Inc. will post 1.16 EPS for the current year.

Institutional Investors Weigh In On Astrana Health

Several hedge funds have recently bought and sold shares of ASTH. GAMMA Investing LLC bought a new stake in Astrana Health in the third quarter valued at approximately $34,000. Nisa Investment Advisors LLC acquired a new stake in Astrana Health during the 3rd quarter valued at $35,000. KBC Group NV bought a new position in Astrana Health during the third quarter worth $70,000. Quarry LP acquired a new position in shares of Astrana Health in the third quarter valued at $77,000. Finally, Quest Partners LLC acquired a new stake in shares of Astrana Health during the 3rd quarter worth about $133,000. 52.77% of the stock is currently owned by institutional investors and hedge funds.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.